Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus

By sjmartinez • March 15, 2025

Zhang Y, Tedeschi SK, Abhishek A, Hensey O, Grossberg D, Cai K, Shea B, Singh JA, Christensen R, Serban T, Cipolletta E, Parperis K, Diaz-Torne C, McCarthy GM, Becce F, Gheita TA, Sirotti S, Christiansen SN, Coronel L, Stamp LK, Abdel-Fattah YH, Pascart T, Filippou G, Hong LE, FitzGerald J, Dalbeth N. Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus. Semin Arthritis Rheum. 2025 Mar 7;72:152669. doi: 10.1016/j.semarthrit.2025.152669. Epub ahead of print. PMID: 40086154.

Tags: calcium pyrophosphate deposition disease, Core domain set, Delphi, Domain, OMERACT, Publications, Rheumatology, Veterans Administration

The Impact of Intravascular Ultrasound Use on 1-Year Outcomes After Infrapopliteal Endovascular Intervention

Snyder DJ, Zilinyi RS, Kido T, Saleem D, Dreyfus I, Bruce S, Wadden E, Girvin Z, Finn MT, Kirtane AJ, Maehara A, Sethi SS, Parikh[...]

Resting-State Sensory-Motor Connectivity between Hand and Mouth as a Neural Marker of Socioeconomic Disadvantage, Psychosocial Stress, Cognitive Difficulties, Impulsivity, Depression, and Substance Use in Children

Assari S, Donovan A, Najand B, Akhlaghipour G, Mendez MF. Resting-State Sensory-Motor Connectivity between Hand and Mouth as a Neural Marker of Socioeconomic Disadvantage, Psychosocial[...]

Efficacy, Tolerability, and Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) in Kidney Transplant Recipients With Diabetes

Zelada H, Campana M, Kawai K, Redden D, Agarwal G, Gutierrez OM, Kumar V. Efficacy, Tolerability, and Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA)[...]